These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 12230886)
41. Comparison of antiproliferative effects of experimental and established antipsoriatic drugs on human keratinocytes, using a simple 96-well-plate assay. Pol A; Bergers M; Schalkwijk J In Vitro Cell Dev Biol Anim; 2003; 39(1-2):36-42. PubMed ID: 12892525 [TBL] [Abstract][Full Text] [Related]
42. A cell-based high-throughput assay for screening inhibitors of human papillomavirus-16 long control region activity. Lembo D; Donalisio M; De Andrea M; Cornaglia M; Scutera S; Musso T; Landolfo S FASEB J; 2006 Jan; 20(1):148-50. PubMed ID: 16254045 [TBL] [Abstract][Full Text] [Related]
43. Picea mariana polyphenolic extract inhibits phlogogenic mediators produced by TNF-α-activated psoriatic keratinocytes: Impact on NF-κB pathway. García-Pérez ME; Allaeys I; Rusu D; Pouliot R; Janezic TS; Poubelle PE J Ethnopharmacol; 2014; 151(1):265-78. PubMed ID: 24189030 [TBL] [Abstract][Full Text] [Related]
44. Regulation of parathyroid hormone-like peptide in cultured normal human keratinocytes. Effect of growth factors and 1,25 dihydroxyvitamin D3 on gene expression and secretion. Kremer R; Karaplis AC; Henderson J; Gulliver W; Banville D; Hendy GN; Goltzman D J Clin Invest; 1991 Mar; 87(3):884-93. PubMed ID: 1999499 [TBL] [Abstract][Full Text] [Related]
45. The anti-apoptotic protein G1P3 is overexpressed in psoriasis and regulated by the non-coding RNA, PRINS. Szegedi K; Sonkoly E; Nagy N; Németh IB; Bata-Csörgo Z; Kemény L; Dobozy A; Széll M Exp Dermatol; 2010 Mar; 19(3):269-78. PubMed ID: 20377629 [TBL] [Abstract][Full Text] [Related]
46. MiR-217 is down-regulated in psoriasis and promotes keratinocyte differentiation via targeting GRHL2. Zhu H; Hou L; Liu J; Li Z Biochem Biophys Res Commun; 2016 Feb; 471(1):169-76. PubMed ID: 26826389 [TBL] [Abstract][Full Text] [Related]
47. IL-1 activity is reduced in psoriatic skin. Decreased IL-1 alpha and increased nonfunctional IL-1 beta. Cooper KD; Hammerberg C; Baadsgaard O; Elder JT; Chan LS; Sauder DN; Voorhees JJ; Fisher G J Immunol; 1990 Jun; 144(12):4593-603. PubMed ID: 2191038 [TBL] [Abstract][Full Text] [Related]
48. Demonstration of skin-derived antileukoproteinase (SKALP) in urine of psoriatic patients. Alkemade H; van de Kerkhof P; Schalkwijk J J Invest Dermatol; 1992 Jul; 99(1):3-7. PubMed ID: 1607676 [TBL] [Abstract][Full Text] [Related]
49. Development and application of monoclonal antibodies against SKALP/elafin and other trappin family members. Vandermeeren M; Daneels G; Bergers M; van Vlijmen-Willems I; Pol A; Geysen J; Schalkwijk J Arch Dermatol Res; 2001 Jul; 293(7):343-9. PubMed ID: 11550807 [TBL] [Abstract][Full Text] [Related]
50. Molecular cloning and expression of human keratinocyte proline-rich protein (hKPRP), an epidermal marker isolated from calcium-induced differentiating keratinocytes. Lee WH; Jang S; Lee JS; Lee Y; Seo EY; You KH; Lee SC; Nam KI; Kim JM; Kee SH; Yang JM; Seo YJ; Park JK; Kim CD; Lee JH J Invest Dermatol; 2005 Nov; 125(5):995-1000. PubMed ID: 16297201 [TBL] [Abstract][Full Text] [Related]
51. Therapeutic efficacy of the suicide gene driven by the promoter of vascular endothelial growth factor gene against hypoxic tumor cells. Koshikawa N; Takenaga K; Tagawa M; Sakiyama S Cancer Res; 2000 Jun; 60(11):2936-41. PubMed ID: 10850440 [TBL] [Abstract][Full Text] [Related]
52. Control of transgene expression using local hyperthermia in combination with a heat-sensitive promoter. Vekris A; Maurange C; Moonen C; Mazurier F; De Verneuil H; Canioni P; Voisin P J Gene Med; 2000; 2(2):89-96. PubMed ID: 10809142 [TBL] [Abstract][Full Text] [Related]
53. Extremely low levels of epidermal skin-derived antileucoproteinase/elafin in a patient with impetigo herpetiformis. Kuijpers AL; Schalkwijk J; Rulo HF; Peperkamp JJ; van de Kerkhof PC; de Jong EM Br J Dermatol; 1997 Jul; 137(1):123-9. PubMed ID: 9274639 [TBL] [Abstract][Full Text] [Related]
54. Development and application of a GFP-FRET intracellular caspase assay for drug screening. Jones J; Heim R; Hare E; Stack J; Pollok BA J Biomol Screen; 2000 Oct; 5(5):307-18. PubMed ID: 11080689 [TBL] [Abstract][Full Text] [Related]
55. High-throughput cell-based screening for hepatitis C virus NS3/4A protease inhibitors. Lee JC; Yu MC; Lien TW; Chang CF; Hsu JT Assay Drug Dev Technol; 2005 Aug; 3(4):385-92. PubMed ID: 16180993 [TBL] [Abstract][Full Text] [Related]
56. Identification of promoter regions involved in cell- and developmental stage-specific osteopontin expression in bone, kidney, placenta, and mammary gland: an analysis of transgenic mice. Higashibata Y; Sakuma T; Kawahata H; Fujihara S; Moriyama K; Okada A; Yasui T; Kohri K; Kitamura Y; Nomura S J Bone Miner Res; 2004 Jan; 19(1):78-88. PubMed ID: 14753740 [TBL] [Abstract][Full Text] [Related]
57. Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes. Bata-Csorgo Z; Hammerberg C; Voorhees JJ; Cooper KD J Clin Invest; 1995 Jan; 95(1):317-27. PubMed ID: 7529261 [TBL] [Abstract][Full Text] [Related]
58. Inverse regulation of the nuclear factor-kappaB binding to the p53 and interleukin-8 kappaB response elements in lesional psoriatic skin. Johansen C; Flindt E; Kragballe K; Henningsen J; Westergaard M; Kristiansen K; Iversen L J Invest Dermatol; 2005 Jun; 124(6):1284-92. PubMed ID: 15955105 [TBL] [Abstract][Full Text] [Related]
59. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector. Latham JP; Searle PF; Mautner V; James ND Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585 [TBL] [Abstract][Full Text] [Related]
60. The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal differentiation of osteoclasts. Luchin A; Purdom G; Murphy K; Clark MY; Angel N; Cassady AI; Hume DA; Ostrowski MC J Bone Miner Res; 2000 Mar; 15(3):451-60. PubMed ID: 10750559 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]